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The role of artificial food additives and food chemicals in abetting certain behavioural conditions has been the 
subject of behavioural nutrition research over several decades. However, a few studies have also raised questions 
regarding a similar role possibly played by naturally occurring phytochemicals in general and salicylates in 
particular. Such studies have, however, been rather few and far between. More importantly, till date, there has been 
no attempt to collate the findings from the few studies that have been carried out at different points in time by 
different researchers across different countries and cultures. This gap in the extant body of knowledge is made 
especially prominent by the fact that naturally occurring salicylates abound in many green vegetables and fruit, 
which are common constituents of a healthy diet. The aim of this review article is two-fold – firstly, to collate and 
present the related researches on the effects of salicylates in general and natural salicylates in particular on mental 
health; and secondly, to identify promising research directions for the future. 
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1. Background and motivation
That diet can have an effect on physical as well as mental health is an idea that can be traced 
back to antiquity (coSMan, 1983; Kanarek & Orthen-GaMBill, 1986). Ancient Egyptians 
believed that some foods had certain special “powers” over the human mind, e.g. salty foods 
were thought to stimulate passion, while onions were thought to have a calming effect and 
induce sleep (DarBy, 1977). In the classical Greek poem Odyssey, good and bad human traits 
were attributed to the type of food people consumed (Flint-haMilton, 1999). Offerings to 
ancient Hellenic deities mainly consisted of meat and breads, while fruit and vegetables were 
thought not to possess the intrinsic qualities that could stimulate heroic acts and behaviour 
and were “considered beneath dignity of gods and heroes” (NeStle, 1995). In ancient Indian 
medicine, different personality types were classified based among other things, on the 
components of one’s diet, and eating habit was considered of vital importance to healthy life 
(Mukherjee, 2007). It was, however, only during the early decades of the twentieth century 
that physiologists started to investigate clinically the effects of diet on behavioural disorders. 
Shannon (1922) formally hypothesized a role of certain dietary components on neuro-
pathological manifestations in children. Lennox and CoBB (1928) for the first time scientifically 
studied the therapeutic effects of a ketogenic diet on the frequency and severity of epileptic 
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seizures. Later research along these lines has focused on the impact of diet components on 
several behavioural disorders, especially in children. However, while relevant literature is 
replete with studies of effects of diet on behavioural disorders ranging from autism to 
depression (Soh et al., 2009), there are surprisingly few reviews of research to date that 
investigated the association of a specific diet component with one or more of these disorders. 
Methodologically speaking, the study of effects of diet on behaviour is not much 
dissimilar from a study of the effects of drugs/medications on behaviour. However, the former 
often has an added layer of complexity in terms of biochemically isolating the exact 
constituents of a diet. While in studies involving the effect of drugs on behaviour (usually 
applying some form of a dose-response model), one can be quite sure about the chemical 
characteristics of the drugs being administered as those can be satisfactorily ‘homogenized’, 
the same cannot always be done for all the components of a diet. Ideally, several levels of the 
target nutritional variable ought to be included in an experiment to correctly determine the 
true mathematical form of the dose-response curve. However, foods tend to contain many 
organic and inorganic constituents that may be naturally occurring or present as additives 
(e.g. naturally-occurring versus added sugars) and their respective detrimental psycho-
physical effects. Murphy and JohnSon (2003) have argued that it is rather difficult to 
satisfactorily isolate the effects of natural versus added sugars, because even the so-called 
healthy diets that are largely based on fruit and vegetables do contain significant amounts of 
‘locked in’ natural sugars (monosaccharides and disaccharides). Therefore, a complete and 
truly informative study of the effects of naturally-occurring versus added sugars would have 
to look at their comparative effects on psycho-physical health that, unfortunately, is nigh 
impossible in the absence of reliable data on the break-up of total sugar content between 
added and naturally-occurring for every single component of a particular diet (Murphy & 
JohnSon, 2003). 
Like sugars, there is another diet component that has also received some academic 
attention, especially in the past three or four decades, and these are the naturally-occurring 
salicylates. Salicylates are chemicals that occur naturally in many plants as a part of their 
internal defence against pests and diseases. So, we end up ingesting salicylates in their natural 
form (at varying levels) when we consume certain fruits, vegetables, and plant-derived foods. 
The benefits of a low-salicylate diet began to get identified a little over three decades ago and 
rigorous scientific research in this regard is still at a rather nascent stage. While most of the 
extant research on the effect of naturally-occurring salicylates is concentrated on the 
physiological manifestations of salicylate intolerance such as migraines, eczema, and irritable 
bowel syndrome, some researchers have also explored their role in behavioural disorders, 
especially in children, for example autism and the attention deficit hyperactivity disorder 
(ADHD) (Food Intolerance Network website). The study of salicylates in psycho-physical 
health has proven to be rather controversial and an especially difficult one to be targeted in 
clinical research because, unlike the other well-known ‘nasties’, e.g. fats and sugars, 
naturally-occurring salicylates are commonly found locked in a number of plant-derived 
foods that are normally considered essential ingredients of a healthy diet. 
This paper is structured as follows: the next section gives a broad introduction to 
salicylates; the subsequent four sections each respectively review the literature on the effect 
of natural salicylates on ADHD, autism, schizophrenia, and depression; and then the 
concluding section sums up the article. In performing this review, the Google Scholar and 
PubMed databases were searched sequentially using the keywords diet, salicylates, 
behavioural disorders, ADHD, autism, schizophrenia, depression.
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2. What are salicylates?
Salicylic acid [C6H4(OH)COOH] is a plant secondary metabolite primarily derived from 
trans-cinnamic acid and benzoic acid via the phenylpropanoid pathway and is a vital 
component of the plant’s systemic acquired resistance system that enhances autonomic 
resistance to pathogen invasion (paterSon et al., 2008). AspirinTM (acetyl-salicylic acid) has 
been used pharmaceutically for over a century to treat localized pains and inflammations; and 
is obtained via esterification of the phenolic hydroxyl group of salicylic acid with the acetyl 
group from either of acetic anhydride or acetyl chloride (jeFFreyS, 2004). pierpoint (2002) 
had also posited other likely roles of salicylates in plants, e.g. flowering stimulation, 
germination, and growth regulation. This might also explain the predominance of plant-based 
potions and remedies used in the olden days to treat pain and injuries. BoSetti and co-workers 
(2001) have also reported that regular intake of aspirin is associated with a decreased 
incidence of colon cancer. Many fruits, vegetables herbs, and spices used for human 
consumption contain natural salicylates mainly as salicylic acid and its various esters – so it 
has been suggested that the recognised effects of a diet composed largely of fruit and 
vegetables, on lowering bowel cancer risk, may at least partly be attributed to the presence of 
naturally occurring salicylates (paterSon & lawrence, 2001). There is very little research 
that documents the natural salicylate contents of various food items in a typical modern 
Western diet; and to make matters more complicated, whatever little information is out there 
happens to be rather conflicting. Among the well-cited works in this regard, Swain and co-
workers (1985), VeneMa and co-workers (1996), and paterSon and co-workers (2006) have 
reported the content (mg/kilogram) of natural salicylates in some common food items in a 
typical modern Western diet. A more exhaustive chart of food items with information on 
naturally occurring salicylate levels is freely downloadable from the popular site ‘EVERYDAY 
WITH ADHD’.
While the beneficial effects of salicylate-rich foods (mainly fruits, vegetables, and other 
plant-derived products) in human diet have been extensively researched and documented, in 
recent years some attention has been drawn to some of the detrimental effects of salicylates 
on psycho-physical health. While dietitians and nutritionists throughout the developed world 
are advocating a diet rich in plant-based foods to combat increasing obesity and related 
ailments, especially amongst children and young adults, the research on the negative effects 
of naturally occurring salicylates has opened up the debate over the ‘ideal’ diet. It is against 
the above backdrop that a review of the current research on what we know of the role played 
by salicylates in general and naturally occurring salicylates in particular in some of the 
common behavioural disorders assumes relevance. 
3. Salicylates and attention deficit hyperactivity disorder (ADHD)
Attention deficit hyperactivity disorder (ADHD) is the most common psychiatric disorder of 
childhood, affecting around 8% of US school-aged children aged between four and seventeen 
years, who exhibit the tell-tale signs of being inattentive, impulsive, and hyperactive and are 
often also affected by a host of other co-occurring psychological and learning disorders 
(SteVenS et al., 2011). Although a variety of medical treatments and behavioural therapies 
exist for ADHD with fairly good prognosis, many parents are eager to explore alternative 
remedies to try and avoid the unwanted side effects of the former and the usually very long 
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administration times of the latter. While the exact causes of ADHD are still unknown, 
symptoms are associated with dopaminergic and noradrenergic transmission, involving 
genetic as well as environmental factors (SteVenS et al., 2011). 
FeinGolD (1973, 1975) was the first to propose, somewhat controversially, that a likely 
environmental trigger of ADHD is the ingestion of certain foods/food additives to which 
subjects are hypersensitive. His proposition was mainly founded on his own clinical 
experiences treating aspirin-sensitive patients with behavioural problems (rojaS & chan, 
2005). The famous Kaiser-Permanente (K-P) diet (later known as the Feingold program) was 
subsequently formulated that specifically labelled natural salicylates as one of the key food-
related ADHD triggers. Since the original proposition by Feingold, there have been several 
experimental studies to test the efficacy of the K-P diet in treating ADHD-affected children 
(e.g. connerS et al., 1976; harley et al., 1978; kaVale & ForneSS, 1983; GroSS et al., 1987). 
However, these studies did not specifically target natural salicylates in foods, rather testing 
for the efficacy of the K-P diet overall, which restricts ingestion of artificial food additives 
and preservatives along with consumption of some specific food items that contain natural 
salicylates, such as apples, oranges, berries, tomatoes, teas, and certain spices.  FitzSiMon and 
co-workers (1978) first attempted to isolate the salicylate-specific effect on ADHD by 
studying the changes to triggered behavioural responses in hypersensitive children. But their 
study used a 40-mg purified acetyl-salicylic acid tablet (against a similar looking ascorbic 
acid placebo) instead of natural salicylate-containing food items. They found significant 
differences between the treatment and control subjects in terms of general cognitive capacity, 
line walking, and disturbance in normal sleep patterns. However, there are no such studies yet 
on the effect of natural salicylates in food.
The potential association of salicylate intake and ADHD was addressed in a comparative 
study of the nutritional pattern of school children with ADHD with that of normal children 
(aMani & khajeh MouGahi, 2005). Their study group was made up of four hundred school-
age children in a middle-eastern city where the parents and teachers completed the socio-
economic, anthropometric, and bio-behavioural scoring questionnaires specifically designed 
for this study. They failed to find any significant relationship between consumption of food 
rich in natural salicylates and degree and severity of ADHD. However, school-age boys who 
drank more than three cups of tea a day had a significantly increased severity of ADHD. 
However, although teas have high salicylate content, they also contain other phytochemicals, 
to which the test subjects may have been hypersensitive. 
As can be deduced from a perusal of the extant literature, not a lot of research has 
happened as yet that attempts to clearly isolate the effect of natural salicylates in food items 
on the degree and severity of ADHD. ‘Salicylate’ is a rather general term that includes many 
compounds that contain the basic salicylate radical and the possible varieties include salicylic 
acid, sodium salicylate, methyl salicylate, and acetylsalicylic acid (GooDMan and GilMan, 
1965). The original K-P diet did not specify which of these varieties should be excluded or 
the intake levels at which they can trigger behavioural responses. The biggest roadblock to 
previous research in this regard seems to have been the paucity of reliable data on percentage 
content of various salicylates in specific food items (wenDer, 1986). Armed with an accurate 
chemical compositions database of common food items, researchers can look at setting up 
longitudinal studies using a structured sequence of elimination and challenge diets that can 
help reveal more clearly the causal effects, if any, of natural salicylates on severity of ADHD. 
clarke and co-workers (1996) have provided an elaborate schematic model of the critical 
steps that ought to be involved in a well-designed clinical investigation into pharmacological 
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food intolerance. Similar models have already been widely used in investigating the effect of 
food additives and so it can be argued that they should also be helpful in investigating the 
effect of natural salicylates in food items. perry and co-workers (1996) also acknowledged 
that extant empirical evidence of a positive effect of salicylate-elimination diets in treatment 
of ADHD is at best weak and that further investigations are necessary. However, as yet, there 
does not appear to have been any study conducted that specifically singled out the effect of a 
reduced natural salicylate diet in the treatment of ADHD although there are several which 
have looked at the effect of a reduced artificial food colours and food additives diet. The 
therapeutic effect, if any, of a reduced natural salicylates diet on ADHD patients therefore 
continues to remain an open question to this day. Hence this provides a fertile area for future 
multi-disciplinary research that is likely to involve clinical dieticians, psychiatrists, and 
behaviour therapists.
4. Salicylates and autism
Autism (or autism spectrum disorder) is a developmental, cognitive disorder amongst 
children that mainly manifests as learning, communication, and behavioural impairment 
(Fernell et al., 2007). It was again Feingold who first hypothesized and also provided some 
clinical evidence that salicylates “can produce in addition to hyperkinesis or MBD clinical 
patterns resembling those shown in a variety of neurologic disorders” including autism 
(FeinGolD, 1979). neeDS and BrookS (1985) noted that administering aspirin to children 
could put strain on their livers; which could then trigger a range of adverse physiological and 
behavioural responses. Hence, a variant of the K-P diet (later absorbed within the Feingold 
Program) was formulated for children suffering especially from the autism spectrum 
disorders. However, the efficacy of the K-P diet was challenged on the basis of clinical studies 
conducted under the aegis of important health institutions in the US like the American 
Council on Science and Health (whelan et al., 1980) and the National Institutes of Health 
Consensus Development Conference Statement (nih, 1982). However, Bernard Rimland, a 
noted autism expert of that time, came to the defence of the Feingold hypothesis and counter-
challenged the scientific veracity of the clinical studies based on which the K-P diet was 
being attacked (riMlanD, 1983). Several subsequent researchers have also provided support 
for the Feingold hypothesis, e.g. alBerti and co-workers (1999) observed that salicylates 
tend to have adverse biochemical effects in autistic children and can significantly worsen 
their disease symptoms. It has been conjectured that salicylates, being a subgroup of phenols, 
may be a contributory factor in worsening of symptoms in autistic patients who may have 
problems with breakdown of phenols (SriniVaSan, 2009). Evidence has already been found 
that autistic patients tend to be deficient in a particular enzyme involved in metabolic 
breakdown of phenols and amines – phenol sulphur transferase or PST (warinG & kloVrza, 
2000). 
Relatively recently, patel and curtiS (2007) reported that children with autism spectrum 
disorders responded better to multi-dimensional treatment strategies, which included a 
dietary intervention that restricted or eliminated refined sugar, chemical additives, salicylates, 
and also casein/gluten (if the patient was hypersensitive). However, although it favoured the 
Feingold hypothesis, as with the other dietary studies involving ADHD patients we cited in 
the previous section, this one too was not salicylate-specific. On the other hand, there are also 
some recent evidences that counter the original Feingold hypothesis. For example, eMonD 
and co-workers (2010) studied the comparative feeding habits, dietary patterns, and growth 
349MALAKAR & BHATTACHARYA: DIETARY SALICYLATES AND BEHAVIOURAL HEALTH
Acta Alimentaria 43, 2014
in infants with autism spectrum disorder against normal infants. The afflicted infants were 
found to consume less vegetable and fruit and also less of foods high in additives, e.g. sweets 
and aerated drinks. There were no significant differences with normal infants in terms of 
weight, height, or body mass index at eighteen months and eighty-four months age or in 
haemoglobin count at the latter age. However, the researchers do not clearly state whether the 
children afflicted with autism spectrum disorder ate less fruit and vegetable, etc. simply 
because they were given less of these food items to eat (e.g. because their parents were 
unable to afford these food items on a regular basis) or whether parents deliberately avoided 
giving these food items as they aggravated the symptoms. (If it was the latter then it could in 
fact go in favour of the original hypothesis of Feingold!) GooD (2009) has further pointed out 
that although salicylates, whether ingested with food or administered as aspirin, may worsen 
the behavioural symptoms in already autistic children, there is no evidence indicating they 
can abet autistic regression in normal children.
Like with ADHD, the question of causality between low-salicylate diet and symptoms 
alleviation of autism spectrum disorders is still severely under-researched. The gap in the 
extant literature is even more prominent for salicylates present naturally in a number of fruits, 
vegetables, and plant-sourced food items – the common core ingredients of what one would 
likely consider to be a healthy diet. Given that it is now well-known that autistic patients tend 
to be PST-deficient, causal link between a low-salicylate diet and the mitigation of symptom-
severity seems a rather plausible hypothesis. However, while the literature is replete with 
dietary intervention studies that look at artificial food additives, peer-reviewed studies 
focusing exclusively on the role of a diet low in salicylates in general and natural salicylates 
in particular in treating autism spectrum disorders are conspicuously absent. 
5. Salicylates and schizophrenia 
Schizophrenia is a chronic, severely disabling brain function disorder affecting approximately 
1% of US population (US National Institute of Mental Health). There are behavioural as well 
as genetic causes that potentially underlie this affliction. Deakin and co-workers (1997) have 
observed that a genetic predisposition to schizophrenia is evidenced by significantly 
weakened frontal lobe function and that a loss of fronto-temporal projections leading to 
temporal lobe malfunction causes the manifest psychotic symptoms, which typically include 
severe delusions, episodic visual and/or auditory hallucinations, apathy, etc. The patients can 
become disorientated in their speech and general behaviour, which may be attributed to a 
stunted developmental process of synaptic elimination as they struggle to separate real world 
events, persons, and locations from the illusory ones. The condition can become debilitating 
to the extent that patients have to depend on others for their daily maintenance. While the 
psychotic symptoms can be largely managed with treatment regimes that are currently 
available, a permanent cure for this mental condition is still not at hand. 
Using data obtained from Copenhagen Perinatal Cohort and from the Danish Psychiatric 
Central Register, SørenSen and co-workers (2004) found a statistically significant evidence 
of an elevated risk of schizophrenia from pre-natal exposure to aspirin (adjusted odds ratio 
4.75, 95% CI 1.9 to 12). When the relationship was causal, children born to mothers who 
took aspirin-like analgesics for a length of time that extended into the second trimester of the 
pregnancy would have an increased congenital risk of schizophrenia affliction. But what 
about the effect of natural salicylates present in the environment? Could they too have an 
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impact on prognosis or treatment of schizophrenia affliction? Sørensen’s results are perhaps 
suggestive that food salicylates would never be of sufficiently high quantity to affect normal 
people physiologically, but potential effect on salicylate-sensitive individuals remains 
unknown.
kinG (1981) had argued that allergic reactions may have behavioural manifestations. In 
a double-blind experimental study, King exposed thirty test subjects to several allergens or to 
a placebo and found that behavioural changes were triggered in the presence of allergens but 
not in presence of the placebo. Although allergy symptoms are normally associated with 
physical disorders, GarFielD (1985) conjectured that severe behavioural disorders like 
clinical depression and schizophrenia may also be abetted by allergies. Food items are one of 
the most common triggers for allergic reactions mediated via IgE antibodies and it is already 
well-known that some persons are hypersensitive to the salicylates contained in many food 
items – both natural as well as added. However, like ADHD and autism, the evidence so far 
of a positive role of low-salicylate diet in treatment of schizophrenia is largely anecdotal with 
a paucity of focused research.   
paterSon and co-workers (2006) conducted a study to investigate the beneficial effect of 
natural salicylates in preventing bowel cancer, for which they recruited a study group from 
village in southern India, where the diet principally consists of local vegetables, grains, and 
pulses seasoned with natural spices and herbs, and is mostly free of any artificial additives. 
What however rather interesting is that their study group consisted of exactly the same 
subjects who were recruited previously for another unrelated study that wanted to investigate 
the prevalence of dyskinesia among first-degree relatives of people diagnosed with 
schizophrenia (MccreaDie et al., 2003). The choice of subjects for their study group by 
McCreadie and co-workers was apparently influenced by the prevalence of cases of untreated 
schizophrenia amongst this particular rural population. This link has not been explored 
further and it merits further study.  
MccreaDie and co-workers (2005), however, carried out a study that could be seen to 
challenge the idea that natural salicylates in diet could worsen the symptoms of schizophrenia 
affliction. They hypothesized that people with schizophrenia make poor dietary choices, 
which leads to obesity and other health complications. They set up three ‘treatments’ – the 
first consisted of six months’ supply of free fruits and vegetables along with instructions on 
planning a healthy diet, the second consisted of six months’ supply of free fruits and vegetables 
but no instructions, and the third was ‘status quo’, i.e. the usual diets were continued. They 
randomly allocated these three ‘treatments’ among their test subjects. They found that after 
the intervention, those who received the first two ‘treatments’ were consuming significantly 
more fruits and vegetables than those in the ‘status quo’ treatment group. Consumption of 
fruits and vegetables was reported to fall to pre-intervention levels in a year after intervention 
stopped. However, they do not report any changes in the severity of the symptoms of the 
subjects who received either of the first two ‘treatments’, i.e. who were encouraged to move 
to a diet of fruits and vegetables – food items that tend to be typically quite rich in natural 
salicylates. It is not known whether they actually attempted to measure in any way the pre- 
and post-intervention severity levels of the symptoms, but it can be assumed that subjects did 
not exhibit any marked changes, which one would think, would then have been reported in 
their paper by the researchers.  
More recent studies with pharmacological doses of aspirin have provided evidence for a 
beneficial effect on schizophrenic patients in reducing the severity of the symptoms (Grohol, 
2010a). For example, a randomised placebo-controlled clinical trial found significant 
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improvement in both Positive and Negative Syndrome Scale (PANSS) and psychotic scores 
with aspirin 1000 mg/day than in the placebo-treated group (laan et al., 2010). However, a 
limiting factor was that the patients for this clinical trial were not selected on the basis of 
salicylate hypersensitivity. Nevertheless, whether a similar positive effect could be also 
demonstrated via food-based salicylates, still remains to be tested. 
That diet can have an impact on patients with schizophrenia affliction is well addressed 
in the extant literature. For example, a causal relationship between gluten ingestion and 
severity of schizophrenic symptoms was posited by Dohan (1966). More recently, a lessening 
of the severity of psychotic symptoms of schizophrenia has been reported following a move 
to a low-carbohydrate, ketogenic diet, where the possible reasons were surmised to be gluten 
elimination (for gluten-hypersensitive patients) and “modulation of the disease of 
schizophrenia at the cellular level” (kraFt & weStMan, 2009). reichelt and GarDner (2012) 
have corroborated this and have claimed that dietary intervention can prove helpful for some 
schizophrenia sufferers – an area which they acknowledge as being rather under-researched. 
Therefore, methodologically similar studies investigating the effect of a low-salicylate diet 
on schizophrenia are quite plausible and are strongly warranted given the somewhat 
conflicting landscape revealed by the aspirin studies of SørenSen and co-workers (2004) and 
laan and co-workers (2010).
6. Salicylates and depression
In a normally functioning human brain, the major mood-regulating neurotransmitters like 
dopamine, serotonin, and noradrenaline interact with a sequence of neurons without any 
depletion of signal strength from the first to the second to the subsequent neurons. When 
afflicted with depression, however, these neurotransmitters lose their normal functioning, so 
that the signal is depleted when passed on from one neuron to the next. Aetiologically, 
depressive disorders have a roughly 60–40 split between environmental triggers and genetic 
predisposition. Other factors are: gender - with women more likely than men to suffer the 
‘non-melancholic’ type of depression (i.e. more psychological than physiological in its 
origin), aging – with diminishing brain function, side-effects of diseases – e.g. certain cancers, 
and personality factors – e.g. psychopathological differences (Black Dog Institute website).
In this review, we are particularly focusing on ‘clinical depression’, which is one of the 
most commonly diagnosed forms (SoloMon et al., 2010). Several studies have attempted to 
understand the relation between dietary components and clinical depression. Much attention 
has been paid to the fatty acid content of the diet with variable results (hiBBeln & SaleM, 
1995; eDwarDS et al., 1998; lucaS et al., 2011; Sánchez-VilleGaS et al., 2011). Little 
attention, however, has been paid to dietary salicylates. Indirect potential involvement of 
salicylates in clinical depression derives from the observation that free tryptophan in plasma 
is a significant factor in the turnover of some mood-regulating neurotransmitters like serotonin 
under normal and disease conditions. This might explain any mood-related side effect of 
aspirin that displaces bound tryptophan (paoletti et al., 1975). Actual dietary studies 
specifically to examine the effect of low salicylate-diets on clinical depression are again 
extremely rare. DenGate (2009) talks of a patient who was suffering from major depressive 
episodes and was not responding to medication. Four weeks after being put on an elimination 
diet prepared by the Royal Prince Alfred Hospital (RPAH) Allergy Clinic at Sydney, Australia, 
his mood improved remarkably and also the depressive episodes along with other 
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psychological symptoms were greatly diminished. This special diet eliminates approximately 
fifty artificial additives in food and medicines as well as naturally occurring salicylates. 
While this patient was actually found to be allergic to some of the artificial additives, it is 
plausible that patients afflicted with clinical depression who are salicylate-hypersensitive 
may respond similarly. This particular case was earlier published as a clinical study (parker 
& watkinS, 2002), wherein the researchers had concluded that food intolerance could be a 
contributing factor in major depressive disorders that must be taken into consideration before 
prescribing anti-depressant medication or preparing a treatment regimen. Also there is 
empirical evidence, which suggests that individuals (especially females) who had developed 
ADHD as children have a significantly higher likelihood of developing clinical depression as 
adults (Faraone, 2006; BieDerMan et al., 2006, 2010; Grohol, 2010b). This implicates 
salicylates in at least an indirect involvement – as a trigger for ADHD symptoms in children, 
who then have a stronger predisposition to develop clinical depression when they grow up. 
walker and co-workers (2008) has reported that patients of inflammatory bowel disease 
(IBD) have a significantly higher long-term risk of developing clinical depression compared 
to normal population. MoScanDrew and co-workers (2009) have also corroborated that 
clinicians must be aware of the high co-morbidity risk of IBD patients suffering from 
depression while screening them for the state of the disease and also while implementing a 
specific treatment regime. Interestingly, it is also quite well-known that many IBD patients 
are salicylate-hypersensitive, clearly evidenced by their poor response to aspirin administration 
as an anti-inflammatory drug (DaVieS, 1995; roBinSon et al., 1995). So, a latent link between 
salicylic acid (and its compounds) and clinical depression is plausible and poses an interesting 
research problem begging a deeper inquiry. 
While there are some indirect implications for a possible role of salicylates as a 
contributing/exacerbating factor in clinical depression, no compelling evidence has been 
seen as yet. haMDan (2008) has observed that high blood concentrations of salicylates can 
cause delirium and other psychotic episodes; so this may be seen to abet manic-depressive 
types of behaviour; but this is again in a toxico-pharmacological rather than a dietary context. 
There are no studies yet that show whether at all, and if so, then at what levels can the intake 
of salicylate-rich foods trigger depression. 
7. Conclusion: what the current landscape looks like –  
implications for mental health
It is quite apparent from the above discussions that Feingold hypothesis is still the central 
theoretical edifice when it comes to explaining the possible role of salicylates in several 
behavioural disorders. However, the Feingold hypothesis, even after more than three decades, 
continues to be controversial with no definite evidence to either unconditionally accept or 
reject the same. ADHD is clearly the behavioural disorder that has been at the focal point of 
most clinical research into the effectiveness of the Feingold program as a therapeutic dietary 
regimen. However, studies that have specifically tried to isolate the effect of salicylates 
(which is only one of the several elimination items in a typical Feingold diet) are few, and in 
those the effect of naturally occurring salicylates in common food items has not been studied. 
Rather, the preference has been to concentrate on dose-response behaviour of the 
pharmacological forms and doses of the compound. But what the current landscape does 
reveal are some interesting questions/problems that should spur future inter-disciplinary 
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research with a potential to unearth crucial latent facts and links. Some of the open questions 
that have been uncovered through this review are highlighted below: 
 (i) What are the therapeutic effects, if any, on ADHD-afflicted children of a diet that 
specifically eliminates salicylates? 
(ii) Given that autism patients tend to be PST-deficient, can salicylates elimination lead 
to a significantly better prognosis? 
(iii) Whether, and if so, then why does a specific, closed population with a vegetarian 
diet consisting of food items rich in natural salicylates have a significantly higher incidence 
of schizophrenia? 
(iv) How does one reconcile the conflicting evidence on the role of salicylates in 
schizophrenia as reported by SørenSen et al. (2004) and lann and co-workers (2010)?
(v) Given that some IBD patients can be salicylate-hypersensitive and clinical depression 
has a significantly high co-morbidity risk with IBD, can a low-salicylates diet help in clinical 
depression?
Major limitations for assessing the effect of dietary salicylates include, first and foremost, 
the huge variance of reporting of salicylate content of foods. Such reporting is essential, since 
dose appears to be very important in salicylate-mediated effects. Pharmacological doses 
would seem unlikely to be achieved by dietary salicylates. Secondly, it is not yet clearly 
established wether or not all forms of salicylates (including plant derived ones) have a similar 
end effect from a pharmacological perspective. Thirdly, low-salicylates diets tend to be less 
flavoursome and palatable. Since compliance with dietary regimens is important for efficacy 
of a diet, this provides an unwanted added difficulty. Compliance typically needs more than 
simply finding a least-cost diet plan that meets the recommended nutritional requirements – 
diets also need to be matched with patients’ ‘coping skills’ and metabolic types (Brownell & 
cohen, 1995; aDaMS et al., 2011; naBin et al., 2013). As has been noted as our major 
motivation for this work, natural salicylates occur mostly in food items that typically are 
included in ‘healthy’ (e.g. low-fat, low-sucrose, low-sodium, etc.) diets. Therefore, 
formulation of a range of low-salicylate diets that also have low ‘drop-out’ rates is likely to 
prove challenging and therefore stimulate further productive research into these areas as 
well. This is made more difficult by the fact that a diet low in natural salicylates is likely to 
be deficient in some of the essential ingredients of an otherwise healthy diet. The formulation 
of an optimal low-salicylate diet that is not nutritionally deficient, palatable as well as 
economical to comply with on a day-to-day basis is a particularly testing problem, especially 
in the absence of more concrete, conflict-free information on the salicylate content of various 
food items. Moreover, it is only after a causal link has been empirically established between 
dietary intake levels of salicylates and the risk of exacerbated symptom severity for 
behavioural disorders, that one can then look at the other related problem areas, e.g. 
formulation of alternative diets and ensuring better compliance to dietary regimen. Very 
recently, a paper published in the Medical Journal of Australia (Gray et al., 2013) has opened 
the Pandora’s Box on the entire issue of clinical efficacy of low-salicylate diets, stirring up a 
huge debate and, unfortunately, more conflicting viewpoints. The open questions as listed 
above and the extant literature from which these have been mined, do nevertheless suggest a 
potentially rich multi-disciplinary research area that is hitherto largely unexplored. There is 
a present and urgent need for both broader as well as deeper investigations that would 
academically inform the pertinent disciplines and improve the current state of clinical 
practice, especially when advocating typical ‘healthy’ eating plans.
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